2026 Apr, 87 (13_Supplement) A187A188
Although preclinical studies suggest that GLP-1RAs may attenuate Alzheimers disease (AD) progression [44, 45], phase III semaglutide trials (NCT04777396, NCT04777409) did not demonstrate clinical benefit
In this regard, more non-Asian data are needed to support this in the future
Common Side Effects When taking semaglutide, some side effects are more common than others
At Continental Hospitals, the best hospital in Hyderabad, our specialists provide personalized, evidence-based care backed by international accreditations and advanced facilities
At Newport Beach UC, patients have access to safe, medically supervised treatment that addresses both weight loss and long-term health